Bring on the good news Mr. Pidduck!One look at the increase in Adastra's (XTRX) shareprice over the past couple weeks is proof enough that there is lots of upside potential still left in this sector if LAB's can give the markets something positive to chew on.
An announcement identifying Medipharms global pharma partner and progress could do just that.
Lets see what the Q4 / Annual financials have to offer ....................